Abstract:Macrocyclic peptides are predominantly peptide structures bearing one or more rings and spanning multiple amino acid residues. Macrocyclization has become a common approach for improving the pharmacological properties and bioactivity of peptides. A variety of ribosomal-derived and non-ribosomal synthesized cyclization approaches have been established. The biosynthesis of backbone macrocyclic peptides using seven new emerging methodologies will be discussed with regard to the features and strengths of each platform rather than medicinal chemistry tools. The mRNA display variant, known as the random nonstandard peptide integrated discovery (RaPID) platform, utilizes flexible in vitro translation (FIT) to access macrocyclic peptides containing nonproteinogenic amino acids (NAAs). As a new discovery approach, the ribosomally synthesized and post-translationally modified peptides (RiPPs) method involves the combination of ribosomal synthesis and the phage screening platform together with macrocyclization chemistries to generate libraries of macrocyclic peptides. Meanwhile, the split-intein circular ligation of peptides and proteins (SICLOPPS) approach relies on the in vivo production of macrocyclic peptides. In vitro and in vivo peptide library screening is discussed as an advanced strategy for cyclic peptide selection. Specifically, biosynthetic bicyclic peptides are highlighted as versatile and attractive modalities. Bicyclic peptides represent another type of promising therapeutics that allow for building blocks with a heterotrimeric conjugate to address intractable challenges and enable multimer complexes via linkers. Additionally, we discuss the cell-free chemoenzymatic synthesis of macrocyclic peptides with a non-ribosomal catalase known as the non-ribosomal synthetase (NRPS) and chemo-enzymatic approach, with recombinant thioesterase (TE) domains. Novel insights into the use of peptide library tools, activity-based two-hybrid screening, structure diversification, inclusion of NAAs, combinatorial libraries, expanding the toolbox for macrocyclic peptides, bicyclic peptides, chemoenzymatic strategies, and future perspectives are presented. This review highlights the broad spectrum of strategy classes, novel platforms, structure diversity, chemical space, and functionalities of macrocyclic peptides enabled by emerging biosynthetic platforms to achieve bioactivity and for therapeutic purposes.

Large Libraries of Structurally Diverse Macrocycles Suitable for Membrane Permeation

Thiol-to-amine Cyclization Reaction Enables Screening of Large Libraries of Macrocyclic Compounds and the Generation of Sub-Kilodalton Ligands

Cyclization of Peptides with Two Chemical Bridges Affords Large Scaffold Diversities

Linearizable Macrocyclic Peptide Libraries for Affinity Selection-Mass Spectrometry

Employing unnatural promiscuity of sortase to construct peptide macrocycle libraries for ligand discovery

A facile strategy for the construction of a phage display cyclic peptide library for the selection of functional macrocycles

Peptide Macrocycles Developed from Precisely Regulated Multiple Cyclization of Unprotected Peptides

Screening macrocyclic peptide libraries by yeast display allows control of selection process and affinity ranking

Biosynthetic Strategies for Macrocyclic Peptides

Membrane Permeability in a Large Macrocyclic Peptide Driven by a Saddle-Shaped Conformation

Expansive discovery of chemically diverse structured macrocyclic oligoamides

One-Pot Cyclization to Large Peptidomimetic Macrocycles by In Situ-Generated β-Turn-Enforced Folding

Macrocycles and Macrocyclization in Anticancer Drug Discovery: Important Pieces of the Puzzle.

MOrPH-PhD: An Integrated Phage Display Platform for the Discovery of Functional Genetically Encoded Peptide Macrocycles

Cyclic, Cell-Penetrating Peptides Tailor-Made for the Creation of Peptide Libraries with Intrinsic Cell Permeability

Late-stage reshaping of phage-displayed libraries to macrocyclic and bicyclic landscapes using multipurpose linchpin

Design of Thioether Cyclic Peptide Scaffolds with Passive Permeability and Oral Exposure

Peptide/protein-based Macrocycles: from Biological Synthesis to Biomedical Applications

Isothiocyanate Enabled Versatile Cyclizations of Phage Dis-played Peptides for the Discovery of Macrocyclic Binders

The Missing Link(er): A Roadmap to Macrocyclization in Drug Discovery

A general strategy for synthesis of cyclophane-braced peptide macrocycles via palladium-catalysed intramolecular sp3 C−H arylation